XML 17 R4.htm IDEA: XBRL DOCUMENT v3.20.1
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Mar. 31, 2020
Mar. 31, 2019
Operating expenses        
General and administrative $ 1,720,142 $ 2,061,251 $ 3,072,176 $ 3,822,559
Research and development 6,053,047 6,078,786 12,401,715 11,790,996
Total operating expenses (7,773,189) (8,140,037) (15,473,891) (15,613,555)
Other income (expenses)        
Grant income 74,944 74,527 149,888 149,055
Research and development incentive income 717,328 760,990 1,660,543 1,174,672
Interest income, net 70,180 51,465 116,900 130,265
Foreign exchange gain (loss), net (325,960) 54,199 (272,848) 49,693
Total other income, net 536,492 941,181 1,654,483 1,503,685
Net loss before provision for income taxes (7,236,697) (7,198,856) (13,819,408) (14,109,870)
Income tax expense, current (48,048) (9,214) (56,765)
Net loss and comprehensive loss $ (7,236,697) $ (7,246,904) $ (13,828,622) $ (14,166,635)
Net Loss per share        
Basic and diluted (in dollars per share) $ (0.12) $ (0.15) $ (0.24) $ (0.30)
Weighted average number of shares outstanding        
Basic and diluted (in shares) 58,353,954 47,134,686 56,554,037 46,726,649